Antibody-Drug Conjugates in NSCLC: Update on TROPION-PanTumor01 Data - Episode 3
Drs Heist and Peters examine data from the lung cohort of TROPION-PanTumor01 study that focused on dopotomab deruxtecan (Dato-DXd) as an antibody-drug conjugate therapy option.